在治疗黑色素瘤后,红血斑,和硬化斑块
Hareni Srenathan1, Jing Gao1, Eva Kolson Kokohaare2
1Department of Dermatology, Royal Free London NHS Foundation Trust, London, UK.
Skin health and disease
|February 6, 2026
概括
皮肤伪淋巴瘤 (CPL) 可能是免疫检查点抑制剂 (ICI) 的副作用,如 pembrolizumab. 内溶性类固醇注射有效地治疗了黑色素瘤患者的这种药物诱导的CPL.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 免疫检查点抑制剂 (ICI),如 pembrolizumab,用于治疗黑色素瘤.
- 皮肤药物不良反应可以模仿血液恶性瘤.
- 皮肤伪淋巴瘤 (CPL) 是对各种药物的罕见不良反应.
研究的目的:
- 在黑色素瘤患者中报告药物诱导的二次布罗利祖马布CPL病例.
- 为了突出治疗ICI诱导的CPL的内伤类固醇治疗的疗效.
- 强调承认CPL是免疫治疗的不良影响的重要性.
主要方法:
- 一个患有IIIC阶段黑色素瘤的患者,接受了布罗利祖马布治疗,患上了CPL.
- 通过免疫组织化学的活检证实了CD4+反应性淋巴体过程.
- 治疗涉及额头斑块的内伤性三氨醇乙化物.
主要成果:
- 内注射的三氨乙化物导致前额CPL斑块的快速改善和完全消失.
- 背部的CPL斑块在六个月内自发消失.
- 在监测期间没有发现黑色素瘤复发的证据.
结论:
- 皮肤伪淋巴瘤是免疫检查点抑制剂的潜在不良皮肤效应.
- 内溶性类固醇注射是药物诱导的CPL的有效治疗方法.
- 由于持续的免疫反应,CPL即使在免疫疗法结束后也会表现出来.
相关概念视频
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
963
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
963
Anticholinesterase Agents: Poisoning and Treatment
1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
Angle Closure Glaucoma: Treatment
1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K


